Your browser is no longer supported. Please, upgrade your browser.
Settings
PRGO [NYSE]
Perrigo Company plc
Index- P/E- EPS (ttm)-2.51 Insider Own0.10% Shs Outstand133.80M Perf Week-9.23%
Market Cap5.11B Forward P/E14.20 EPS next Y2.66 Insider Trans0.00% Shs Float132.79M Perf Month-15.33%
Income-338.00M PEG- EPS next Q0.66 Inst Own91.50% Short Float3.75% Perf Quarter-5.53%
Sales4.32B P/S1.18 EPS this Y-211.60% Inst Trans4.78% Short Ratio2.34 Perf Half Y-18.12%
Book/sh38.73 P/B0.98 EPS next Y30.71% ROA- Target Price54.75 Perf Year-21.18%
Cash/sh15.37 P/C2.46 EPS next 5Y10.00% ROE- 52W Range38.20 - 50.90 Perf YTD-15.52%
Dividend0.96 P/FCF- EPS past 5Y-43.60% ROI0.90% 52W High-25.78% Beta0.98
Dividend %2.54% Quick Ratio1.60 Sales past 5Y14.00% Gross Margin35.20% 52W Low-1.10% ATR1.31
Employees11500 Current Ratio2.10 Sales Q/Q-19.10% Oper. Margin- RSI (14)24.54 Volatility2.71% 2.73%
OptionableYes Debt/Eq0.69 EPS Q/Q68.80% Profit Margin- Rel Volume0.32 Prev Close38.83
ShortableYes LT Debt/Eq0.56 EarningsNov 10 BMO Payout- Avg Volume2.13M Price37.78
Recom2.80 SMA20-13.57% SMA50-15.19% SMA200-14.30% Volume671,241 Change-2.70%
Oct-14-21Upgrade Raymond James Mkt Perform → Outperform $59
Sep-30-21Upgrade Jefferies Hold → Buy $45 → $63
Apr-07-21Resumed RBC Capital Mkts Sector Perform $51
Jan-06-21Downgrade RBC Capital Mkts Outperform → Sector Perform $59 → $49
Apr-17-20Downgrade Argus Buy → Hold
Mar-24-20Upgrade JP Morgan Neutral → Overweight $57
Mar-20-20Upgrade SVB Leerink Mkt Perform → Outperform $54 → $52
Mar-18-20Upgrade RBC Capital Mkts Sector Perform → Outperform $58
Oct-11-19Upgrade Argus Hold → Buy
Mar-20-19Initiated SunTrust Hold
Nov-13-18Downgrade Berenberg Buy → Hold
Aug-10-18Reiterated Stifel Hold $92 → $87
Jul-30-18Downgrade Argus Buy → Hold
Jul-12-18Downgrade Goldman Neutral → Sell
Jan-03-18Initiated Leerink Partners Mkt Perform $90
Dec-08-17Upgrade Argus Hold → Buy
Nov-10-17Upgrade RBC Capital Mkts Underperform → Sector Perform $64 → $86
Oct-05-17Reiterated UBS Buy $84 → $98
Sep-07-17Initiated Oppenheimer Outperform $88
Aug-11-17Upgrade Goldman Sell → Neutral
Nov-22-21 08:30AM  
Nov-10-21 01:00PM  
12:00PM  
10:15AM  
07:45AM  
07:18AM  
06:30AM  
06:27AM  
Nov-08-21 10:33AM  
08:30AM  
Nov-02-21 11:00AM  
Oct-27-21 03:03PM  
08:34AM  
Oct-18-21 04:12AM  
Oct-05-21 04:30PM  
Oct-01-21 04:44AM  
Sep-30-21 01:40PM  
12:09PM  
10:44AM  
09:36AM  
09:25AM  
09:01AM  
08:31AM  
07:43AM  
05:09AM  
Sep-29-21 07:32PM  
Sep-27-21 01:43PM  
Sep-10-21 11:30AM  
Sep-09-21 10:10AM  
Sep-08-21 03:56PM  
01:20PM  
10:47AM  
09:44AM  
07:46AM  
07:13AM  
06:53AM  
06:40AM  
Sep-07-21 11:41AM  
07:43AM  
03:05AM  
Sep-04-21 09:32AM  
Sep-03-21 06:55PM  
02:21PM  
Aug-13-21 04:41PM  
Aug-11-21 04:48PM  
12:30PM  
10:29AM  
09:25AM  
08:20AM  
08:05AM  
07:41AM  
06:30AM  
04:11AM  
Aug-03-21 10:39AM  
Jul-28-21 03:03PM  
10:59AM  
09:00AM  
Jul-19-21 08:33AM  
Jul-07-21 05:10AM  
Jul-06-21 04:33PM  
09:43AM  
Jun-21-21 09:47AM  
Jun-10-21 01:15PM  
11:30AM  
Jun-03-21 05:58AM  
May-21-21 08:30AM  
May-19-21 08:15AM  
May-18-21 08:30AM  
May-11-21 01:30PM  
11:30AM  
09:11AM  
08:05AM  
06:47AM  
06:30AM  
05:45AM  
Apr-27-21 04:15PM  
Apr-26-21 07:20AM  
Apr-25-21 09:43AM  
Apr-23-21 09:43AM  
Apr-22-21 12:33PM  
Apr-19-21 10:35AM  
10:23AM  
Apr-14-21 03:54PM  
Mar-28-21 11:42AM  
Mar-23-21 11:10AM  
10:55AM  
Mar-10-21 10:14AM  
Mar-04-21 02:34AM  
Mar-01-21 01:00PM  
12:45PM  
10:33AM  
08:25AM  
08:08AM  
07:46AM  
07:27AM  
07:18AM  
07:05AM  
06:30AM  
04:44AM  
Feb-26-21 10:03AM  
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the brand names of Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, and Dr. Fresh. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 30 countries, primarily in Europe. The Prescription Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations in the United States, as well as pharmaceutical and diagnostic products in Israel. In addition, it offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Doyle Katherine C.DirectorAug 12Option Exercise41.285,637232,6955,637Aug 16 12:02 PM
Alford Bradley ADirectorMay 07Option Exercise42.965,804249,34013,764May 11 03:06 PM
Mann Erica LDirectorMay 07Option Exercise42.965,804249,3408,709May 11 02:57 PM
Samuels Theodore R. IIDirectorMay 07Option Exercise42.965,804249,34020,094May 11 02:58 PM
Parker Geoffrey M.DirectorMay 07Option Exercise42.965,804249,34014,245May 11 02:56 PM
KINDLER JEFFREY BDirectorMay 07Option Exercise42.965,804249,34013,761May 11 02:57 PM
Karaboutis AdrianaDirectorMay 07Option Exercise42.965,804249,34013,233May 11 02:55 PM
CLASSON ROLF ADirectorMay 07Option Exercise42.967,255311,67518,125May 11 02:56 PM
O'Connor DonalDirectorMay 07Option Exercise42.965,804249,34016,241May 11 02:56 PM
SILCOCK RAYMONDEVP, Chief Financial OfficerApr 05Option Exercise40.393,964160,10610,196Apr 07 11:46 AM
Parker Geoffrey M.DirectorMar 17Buy41.292,500103,2182,650Mar 18 02:45 PM
Janish Ronald CraigEVP, Gbl Ops & SC & CTOMar 10Sale41.232,662109,76611,731Mar 11 03:57 PM
Willis RobertEVP & CHROMar 08Option Exercise41.8269729,1493,934Mar 09 09:17 PM
SILCOCK RAYMONDEVP, Chief Financial OfficerMar 05Option Exercise41.043,629148,9346,232Mar 09 09:19 PM
Kochan SharonEVP & President RxMar 05Option Exercise41.044,057166,49938,748Mar 09 09:19 PM
KESSLER MURRAY SCEOMar 05Option Exercise41.0430,4461,249,50449,164Mar 09 09:19 PM
Dillard James E IIIEVP, Chief Scientific OfficerMar 05Option Exercise41.044,322177,37511,173Mar 09 09:17 PM
Farrington ThomasEVP and CIOMar 05Option Exercise41.042,730112,03918,468Mar 09 09:18 PM
Sorota Richard SEVP & President CSCAMar 05Option Exercise41.042,540104,24210,053Mar 09 09:18 PM
Janish Ronald CraigEVP, Gbl Ops & SC & CTOMar 05Option Exercise41.043,339137,03314,835Mar 09 09:16 PM
Quinn GrainneEVP, Chief Medical OfficerMar 05Option Exercise41.042,27993,5307,299Mar 09 09:17 PM
Willis RobertEVP & CHROMar 05Option Exercise41.042,08385,4864,788Mar 09 09:17 PM
Andersen SvendEVP & President CHCIMar 05Option Exercise41.045,500225,72019,161Mar 09 09:15 PM
KINGMA TODD WExecutive VP, General CounselMar 05Option Exercise41.045,500225,72049,523Mar 09 09:16 PM
Dillard James E IIIEVP, Chief Scientific OfficerFeb 05Option Exercise0.004,29708,913Feb 08 07:27 AM
Sorota Richard SEVP & President CSCAJan 06Buy43.487,513326,6657,513Jan 07 12:31 PM